TH85486B - compound - Google Patents
compoundInfo
- Publication number
- TH85486B TH85486B TH501006061A TH0501006061A TH85486B TH 85486 B TH85486 B TH 85486B TH 501006061 A TH501006061 A TH 501006061A TH 0501006061 A TH0501006061 A TH 0501006061A TH 85486 B TH85486 B TH 85486B
- Authority
- TH
- Thailand
- Prior art keywords
- salts
- alkyl
- compounds
- chemical formula
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 4
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 125000005332 alkyl sulfoxy group Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005059 halophenyl group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Abstract
การประดิษฐ์นี้เกี่ยวกับสารประกอบที่มีสูตร (I), หรือเกลือหรือซอลเวทของสารเหล่านั้น, การใช้สารเหล่านั้นในการผลิตยาสำหรับรักษาความผิดปกติที่เกี่ยวกับระบบประสาท และที่เกี่ยวกับ ประสาทวิทยา และจิตเวชศาสตร์, ที่เฉพาะเจาะจงคือโรคจิต, ภาวะสมองเสื่อมหรือความผิดปกติที่ เกี่ยวกับสมาธิสั้น การประดิษฐ์นี้ประกอบรวมต่อไปด้วยกรรมวิธีเตรียมสารประกอบเหล่านี้ และสูตรผสมทางเภสัชศาสตร์ของสารเหล่านั้น (สูตรเคมี) (I) The invention deals with compounds with formulas (I), or their salts or salts, their use in the manufacture of drugs for the treatment of neurological disorders. And with regards to neurology and psychiatry, the specificity is psychosis, dementia or dysfunction that About ADHD This invention continues with the process of preparing these compounds. And the pharmacological formulation of those substances (chemical formula) (I)
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH85486B true TH85486B (en) | 2007-07-12 |
| TH85486A TH85486A (en) | 2007-07-12 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR090203A1 (en) | HETEROBICICLIC COMPOUNDS AS PDE INHIBITORS10 | |
| PE20141010A1 (en) | PYRIDIN-2 (1H) -ONE DERIVATIVES USEFUL AS MEDICINES FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS, TRANSPLANT REJECTION, IMMUNE-MEDIATED DISEASES, AND INFLAMMATORY DISEASES | |
| JP6643247B2 (en) | Chromene and 1,1a, 2,7B-tetrahydrocyclopropa [C] chromenpyridopyrazinedione as gamma secretase modulator | |
| AR078157A1 (en) | DERIVATIVES OF PIRAZOL- [4,5-D] PIRROLO [2,3-B] PYRIDINE INHIBITORS OF JAK 2 THYROSINQUINASES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USE OF THE SAME IN THE TREATMENT OF CANCER | |
| AR054084A1 (en) | DERIVATIVES OF INDOLCARBOXAMIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MX2017002241A (en) | AMINOPIRIMIDINE COMPOUNDS AS JAK INHIBITORS. | |
| JP2017509689A5 (en) | ||
| US20150087825A1 (en) | Spirocyclic digydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof | |
| JP2017508733A5 (en) | ||
| FR2881732B1 (en) | PROCESS FOR THE PURIFICATION OF HYDROGEN CHLORIDE | |
| AR065333A1 (en) | RAPIDA DISOCIATION DOPAMINE 2 RECEIVER ANTAGONISTS | |
| AR070885A1 (en) | AZAINDOL COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| WO2010000030A1 (en) | Thiazopyrimidinones and uses thereof | |
| MX369974B (en) | Pharmaceutical compounds. | |
| HRP20110785T8 (en) | Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands | |
| JP2017535566A5 (en) | ||
| TH85486B (en) | compound | |
| AR066086A1 (en) | DERIVATIVES OF DIHIDRO-BENZO (B) (1,4) DIAZEPIN-2-ONA-SULFONAMIDE | |
| AR055295A1 (en) | INHIBITING COMPOUNDS OF THE GLYCINE CONVEYOR | |
| AR119098A1 (en) | ALTERNATIVE PROCEDURE FOR THE PREPARATION OF 4-PHENYL-5-ALCOXYCARBONYL-2-TIAZOL-2-IL-1,4-DIHYDROPYRIMIDIN-6-IL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO- 1H-IMIDAZO[1,5-A]PYRAZINE-2-IL]-CARBOXYLIC | |
| Song et al. | Synthesis and evaluation of anticonvulsant activities of triazole-incorporated benzothiazoles | |
| WO2010074409A3 (en) | 3-aminopyrrolidine derivatives as ccr2 antagonists | |
| TH88506B (en) | Rapidly dissociated antagonist dopamine receptor 2 | |
| AR119739A1 (en) | JAK INHIBITORS | |
| TH84725A (en) | Indoleil-alkylamine methabolite that is 5-hydroxytrypthamine-6-ligand. |